Form 4 for GNPX Genprex, Inc.
Accepted 2024-12-06 00:00:00 ET · period of report 2024-12-05 · accession 0001437749-24-036886 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-06 | 2024-12-05 | GNPX | Moreno Toscano Jose Antonio | Dir | A - Grant | $0.00 | +4,750 | 7,845 | +153% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-05 | A | A | 4,750 | $0.00 | 7,845 | D | — | — | (F1) This award of Restricted Stock Units ("RSUs") is granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan and vests 100% upon the earlier of (a) June 30, 2025 and (b) the day prior to the Company's next annual meeting of stockholders occurring after the grant date, provided that the recipient continues to serve as a Service Provider (as defined in the Company's 2018 Equity Incentive Plan) through the applicable vesting date. Vested RSUs will be paid in shares of the Company's common stock, $0.001 par value, on a one-to-one basis. (F2) This total represents the amount of securities beneficially owned following this reported transaction and the 1-for-40 reverse stock split of the Company's common stock effected as of February 2, 2024. |